BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/342YG70
via IFTTT